Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martin

Showing results (501-510 of 692) with videos related to

Pageof 70
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trialJavier Martin-Broto, Nadia Hindi, Giovanni Grignani, et al.
Lancet (London, England)|March 9, 2026
Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trialHairong Xu, Xiaohui Niu, Vinod Ravi, et al.
Journal of Autoimmunity|April 10, 2009
Prevalence of hepatitis C serum antibody in autoimmune diseasesNancy Agmon-Levin, Maya Ram, Ori Barzilai, et al.
Molecular Cancer Therapeutics|October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS studyJavier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
European Heart Journal|November 30, 2017
Indications and practical approach to non-invasive ventilation in acute heart failureJosep Masip, W Frank Peacock, Susanna Price, et al.
Cancers|February 9, 2021
Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study ProtocolDide den Hollander, Marco Fiore, Javier Martin-Broto, et al.
European Heart Journal. Acute Cardiovascular Care|July 12, 2023
Comparing the utility of clinical risk scores and integrated clinical judgement in patients with suspected acute coronary syndromeMario Meier, Jasper Boeddinghaus, Thomas Nestelberger, et al.
Molecular Oncology|May 26, 2025
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcomaPiotr J Manasterski, Molly R Danks, John P Thomson, et al.
JAMA|April 8, 2020
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical TrialWilliam D Tap, Andrew J Wagner, Patrick Schöffski, et al.
Pageof 70

Showing results (501-510 of 692) with videos related to

Sort By:
Pageof 70
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trialJavier Martin-Broto, Nadia Hindi, Giovanni Grignani, et al.
Lancet (London, England)|March 9, 2026
Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trialHairong Xu, Xiaohui Niu, Vinod Ravi, et al.
Journal of Autoimmunity|April 10, 2009
Prevalence of hepatitis C serum antibody in autoimmune diseasesNancy Agmon-Levin, Maya Ram, Ori Barzilai, et al.
Molecular Cancer Therapeutics|October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS studyJavier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
European Heart Journal|November 30, 2017
Indications and practical approach to non-invasive ventilation in acute heart failureJosep Masip, W Frank Peacock, Susanna Price, et al.
Cancers|February 9, 2021
Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study ProtocolDide den Hollander, Marco Fiore, Javier Martin-Broto, et al.
European Heart Journal. Acute Cardiovascular Care|July 12, 2023
Comparing the utility of clinical risk scores and integrated clinical judgement in patients with suspected acute coronary syndromeMario Meier, Jasper Boeddinghaus, Thomas Nestelberger, et al.
Molecular Oncology|May 26, 2025
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcomaPiotr J Manasterski, Molly R Danks, John P Thomson, et al.
JAMA|April 8, 2020
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical TrialWilliam D Tap, Andrew J Wagner, Patrick Schöffski, et al.
Pageof 70